Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)
Status:
Completed
Trial end date:
2015-10-23
Target enrollment:
Participant gender:
Summary
This is a Phase II study to test the efficacy of exogenously administered GM-CSF in prostate
cancer patients who have failed definitive local therapy, and have only serologic (PSA)
evidence of progression.